Read + Share
Friedman CF, D'Souza A, Bello Roufai D, Tinker AV, et al. Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results
from the phase 2 SUMMIT basket trial. Gynecol Oncol 2024;181:162-169.
PMID: 38211393
|
 |
|
Friedman CF, D'Souza A, Bello Roufai D, Tinker AV, et al. Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results
from the phase 2 SUMMIT basket trial. Gynecol Oncol 2024;181:162-169.
PMID: 38211393
|
|
|
|